Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATR | Q13535 | 16/20 | 0.59 |
| ▸ | PDCD1 | Q15116 | 16/20 | 0.59 |
| ▸ | CD274 | Q9NZQ7 | 16/20 | 0.59 |
| ▸ | CHEK1 | O14757 | 14/20 | 0.59 |
| ▸ | ATRIP | Q8WXE1 | 14/20 | 0.59 |
| ▸ | MTOR | P42345 | 8/20 | 0.59 |
| ▸ | PIK3CA | P42336 | 3/20 | 0.46 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3723256 | 0.89 | PDCD1 (0.56) | ATRPDCD1CD274CHEK1ATRIP | |
| SCHEMBL3723251 | 0.89 | PDCD1 (0.56) | ATRPDCD1CD274CHEK1ATRIP | |
| SCHEMBL20651520 | 0.83 | PDCD1 (0.74) | ATRPDCD1CD274CHEK1ATRIP | |
| SCHEMBL20651760 | 0.83 | PDCD1 (0.74) | ATRPDCD1CD274CHEK1ATRIP | |
| SCHEMBL3607909 | 0.82 | PIK3CA (0.50) | ATRPDCD1CD274CHEK1ATRIP | |
| SCHEMBL27812275 | 0.81 | MTOR (0.67) | ATRPDCD1CD274CHEK1ATRIP | |
| SCHEMBL3598683 | 0.81 | PIK3CA (0.56) | ATRPDCD1CD274CHEK1ATRIP | |
| SCHEMBL27815303 | 0.81 | ATR (0.49) | ATRPDCD1CD274CHEK1ATRIP | |
| SCHEMBL737810 | 0.80 | PIK3CA (0.55) | ATRPDCD1CD274CHEK1ATRIP | |
| SCHEMBL3608383 | 0.80 | CHEK1 (0.51) | ATRPDCD1CD274CHEK1ATRIP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101541781-B | Morpholino pyrimidine derivatives for the treatment of proliferative diseases | ASTRAZENECA AB | 2014-01-08 | — | — | CN | disclosed |
| CN-101541781-A | Morpholino pyrimidine derivatives for the treatment of proliferative diseases | ASTRAZENECA AB (SE) | 2009-09-23 | — | — | CN | disclosed |